ENGLISH ABSTRACT
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Treatment of tendinopathies: role for autologous platelet-rich plasma injections].

Revue Médicale Suisse 2011 August 11
Chronic degenerative tendinopathies are frequent and difficult to treat. Tendon healing is under influence of many growth factors that can be obtained from patient's blood (platelet-rich plasma). Basic research is quite optimistic but evidence-based studies examining the treatment of human tendinopathies are lacking. Nevertheless, such treatments are increasingly used in clinical practice and expectations of those injections are high. However, the use of autologous blood injections for the management of chronic human tendinopathies can currently not be recommended.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app